EXMceuticals Inc. Receives 45-Day Extension to File Quarterly Financial Statements
29 Mai 2020 - 8:34PM
EXMceuticals Inc. (CSE: EXM)
(FSE: A2PAW2), (the
"Company" or "
EXM"), has provided
an update on the status of the filing of its quarterly financial
statements for the Q3 filings ended March 31, 2020.
On March 18, 2020, the Canadian Securities
Administrators (CSA) announced that they will provide issuers with
a 45-day filing extension for filings required on or before June 1,
2020 to allow issuers the time needed to focus on the many other
business and financial reporting implications of COVID-19. The
Company will rely on this exemption with respect to the quarterly
filings in accordance with BC Instrument 51-515, Temporary
Exemption from Certain Corporate Finance Requirements.
Members of the Company's management and other
insiders are subject to a trading black-out policy that reflects
the principles in section 9 of National Policy 11-207. The Company
expects to file the Documents on or before the end of the available
45-day extension period. An update on material business
developments since the filing of the Company's interim financial
reports has been provided in prior press releases.
On behalf of the Board of Directors of
EXMceuticals Inc.
Jonathan Summers, CEO
For further information, contact:
Jonathan Summers, CEO
Investor Relations
Email: investors@exmceuticals.com
Media Enquiries:
Email: media@exmceuticals.com
Follow us on Twitter:
https://twitter.com/EXMceuticals
Follow us on LinkedIn:
https://www.linkedin.com/company/exmceuticalsinc/
CSE: EXM| FSE: A2PAW2
Neither the CSE nor the FSE has approved nor
disapproved of the contents of this news release. Neither the
CSE nor the FSE accepts responsibility for the adequacy or accuracy
of this release.
Certain information contained herein may
constitute "forward-looking information" under Canadian securities
legislation. Generally, forward-looking information can be
identified by the use of forward-looking terminology such as, "will
be", "expected", "proposes", "intends" or variations of such words
and phrases or statements that certain actions, events or results
"will" occur. Forward-looking statements regarding the Company's
business operations, the extraction of cannabis ingredients and the
exportation of the extracts, the results of testing at our
facilities established for the European market, future laws and
regulations governing the sale of our products in Europe and
elsewhere, and the potential to generate sales, and completion of a
Qualifying Financing, are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of EXM to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
There can be no assurance that such statements will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements and forward-looking information. EXM will not update any
forward-looking statements or forward-looking information that is
incorporated by reference herein, except as required by applicable
securities laws.
EXMceuticals (CSE:EXM)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
EXMceuticals (CSE:EXM)
Historical Stock Chart
Von Dez 2023 bis Dez 2024